Calliditas Therapeutics AB (publ) (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
18.70
+0.95 (5.35%)
Apr 19, 2024, 4:00 PM EDT - Market closed

CALT Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Year 20222021202020192018
Cash & Equivalents
1,249955.51996.3753.54646.18
Cash & Cash Equivalents
1,249955.51996.3753.54646.18
Cash Growth
30.73%-4.09%32.22%16.62%-
Receivables
88.720046.590
Inventory
3.650.89000
Other Current Assets
70.7456.3840.5521.011.79
Total Current Assets
1,4121,0131,037821.13647.97
Property, Plant & Equipment
31.9239.615.416.060.11
Long-Term Investments
11.213.922.231.940.34
Goodwill and Intangibles
483.84399.42418.8316.070
Other Long-Term Assets
13.84.20.600
Total Long-Term Assets
540.77447.14427.0624.070.45
Total Assets
1,9531,4601,464845.2648.42
Accounts Payable
160.467.9753.8324.3822.64
Other Current Liabilities
164.8367.4851.7928.997.6
Total Current Liabilities
325.23135.45105.6253.3730.24
Long-Term Debt
728.82213.220.8800
Other Long-Term Liabilities
132.66102.97101.113.760
Total Long-Term Liabilities
861.48316.18101.993.760
Total Liabilities
1,187451.63207.6157.1330.24
Total Debt
728.82213.220.8800
Debt Growth
241.82%24184.28%---
Retained Earnings
-1,836.32-1,426.57-918.6-488.1-455.52
Shareholders' Equity
766.261,0081,210788.07618.18
Net Cash / Debt
520.27742.29995.43753.54646.18
Net Cash / Debt Growth
-29.91%-25.43%32.10%16.62%-
Working Capital
1,087877.33931.23767.76617.73
Book Value Per Share
25.9340.3852.2934.05-
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).